Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Dzmitry Katovich"'
Autor:
Vera Auchynka, Ajay M.V. Kumar, Hennadz Hurevich, Yuliia Sereda, Varvara Solodovnikova, Dzmitry Katovich, Svetlana Setkina, Askar Yedilbayev, Aliaksandr Skrahin, Alena Skrahina
Publikováno v:
Monaldi Archives for Chest Disease, Vol 91, Iss 1 (2021)
To address the sub-optimal treatment outcomes among patients with multidrug-resistant (MDR-TB) and extensively drug-resistant tuberculosis (XDR-TB), the National TB Programme in Belarus started using new drugs such as bedaquiline and delamanid in 201
Externí odkaz:
https://doaj.org/article/bf448c2529da4c71891fba264ff31239
Autor:
Varvara Solodovnikova, Ajay M.V. Kumar, Hennadz Hurevich, Yuliia Sereda, Vera Auchynka, Dzmitry Katovich, Dzmitry Klimuk, Aliaksandr Skrahin, Svetlana Setkina, Iryna Charnysh, Askar Yedilbayev, Alena Skrahina
Publikováno v:
Monaldi Archives for Chest Disease, Vol 91, Iss 1 (2021)
There is limited evidence describing the safety and effectiveness of bedaquiline and delamanid containing regimens in children and adolescents with Multidrug-Resistant Tuberculosis (MDR-TB) and Extensively Drug-Resistant Tuberculosis (XDR-TB) globall
Externí odkaz:
https://doaj.org/article/61eddf23be564d8bb178f103fce0b2a0
Autor:
Askar Yedilbayev, Dzmitry Katovich, Hennadz Hurevich, Vera Auchynka, Yuliia Sereda, Varvara Solodovnikova, Alena Skrahina, Ajay M. V. Kumar, Aliaksandr Skrahin, Svetlana Setkina
Publikováno v:
Monaldi Archives for Chest Disease, Vol 91, Iss 1 (2021)
To address the sub-optimal treatment outcomes among patients with multidrug-resistant (MDR-TB) and extensively drug-resistant tuberculosis (XDR-TB), the National TB Programme in Belarus started using new drugs such as bedaquiline and delamanid in 201
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b577712fd1e9c304984102c7b8d51d73
https://pubmed.ncbi.nlm.nih.gov/33470081
https://pubmed.ncbi.nlm.nih.gov/33470081